Stock-based Compensation - SARs/Stock Options Roll Forward (Details) - Stock appreciation rights $ / shares in Units, shares in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) $ / shares shares
Number of SARs
Outstanding, beginning of period (in shares) | shares	260
Granted (in shares) | shares	45
Exercised (in shares) | shares	(49)
Cancelled (in shares) | shares	0
Outstanding, end of period (in shares) | shares	256
Vested and expected to vest (in shares) | shares	256
Exercisable (in shares) | shares	160
Weighted- average Exercise Price Per Share
Outstanding, beginning of period (in dollars per share) | $ / shares	$ 51.55
Granted (in dollars per share) | $ / shares	80.85
Exercised (in dollars per share) | $ / shares	42.83
Cancelled (in dollars per share) | $ / shares	0
Outstanding, end of period (in dollars per share) | $ / shares	58.38
Vested and expected to vest (in dollars per share) | $ / shares	58.38
Exercisable (in dollars per share) | $ / shares	$ 50.56
Aggregate Intrinsic Value (thousands)
Outstanding at December 31, 2022 | $	$ 7,448
Vested and expected to vest as of December 31, 2022 | $	7,448
Exercisable at December 31, 2022 | $	$ 5,928
Weighted- average Remaining Term (Years)
Outstanding at December 31, 2021 (in years)	3 years 9 months 18 days
Vested and expected to vest as of December 31, 2021 (in years)	3 years 9 months 18 days
Exercisable at December 31, 2021 (in years)	2 years 9 months 18 days